Mastek (MASTEK) Q4 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 23/24 earnings summary
1 Nov, 2026Executive summary
FY24 revenue reached ₹3,054.8 crore, up 19.2% reported and 13.0% in constant currency; 12-month order backlog rose 15.4% in constant currency to ₹2,168.4 crore.
Q4 revenue was ₹779.7 crore, up 9.9% YoY reported and 6.0% in constant currency; operating EBITDA margin was 16.0%.
Financial highlights
Q4 operating EBITDA was ₹125.1 crore, down 0.3% YoY; PAT was ₹94.4 crore, up 30.1%, and PBT was ₹93.9 crore, down 2.5%.
FY24 operating EBITDA was ₹508.7 crore, up 11.6%; PAT was ₹311.0 crore, up 0.2%, while PBT declined 9.6% to ₹386.2 crore.
FY24 total income was ₹3,070.8 crore, up 18.0%; other income declined 58.2% to ₹16.0 crore.
Q4 basic and diluted EPS were ₹29.9 and ₹29.7; FY24 basic and diluted EPS were ₹98.0 and ₹97.3.
Outlook and guidance
FY25 priorities include US and global healthcare, UK public sector and secure government services, mining the top 30 global accounts, and growth in Oracle, Salesforce, managed services, Data and AI.
GenAI plans span industry solutions, intelligent assistants, GenAI-powered tools, partner solutions, and use cases in healthcare, financial services and retail.
Latest events from Mastek
- 45% consolidated revenue growth was offset by Asia Pacific losses and exceptional charges.MASTEK
Q4 97/98 - Revenue rose 65%, led by US and Europe, while receivables and regional weakness weighed on execution.MASTEK
Q4 98/99 - Revenue rose 53% and profit 205%, while a major US client reduction pressured Q4 results.MASTEK
Q4 99/00 - Revenue growth slowed to 3% as profits fell; Europe offset US weakness.MASTEK
Q4 00/01 - Revenue rose 12%, profits surged, and strategic accounts offset a difficult IT market.MASTEK
Q4 01/02 - Revenue rose 30%, while utilization and selling costs squeezed operating margins.MASTEK
Q4 02/03 - Revenue grew 8%, profits fell, and a record backlog strengthened the FY05 outlook.MASTEK
Q4 03/04 - Record FY05 profit growth, led by UK strength and insurance expansion.MASTEK
Q4 04/05 - Revenue and profit grew strongly as government and insurance led strategy; concentration risks persisted.MASTEK
Q4 05/06